- Home
- LDI vs PACB Comparison
LDI vs PACB Comparison
Compare LDI & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LDI | PACB |
|---|---|---|
| Founded | 2010 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 607.4M | 521.8M |
| IPO Year | 2021 | 2010 |
Fundamental Metrics
Financial Performance| Metric | LDI | PACB |
|---|---|---|
| Price | $1.02 | $1.39 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $3.00 | $1.67 |
| AVG Volume (30 Days) | 1.8M | ★ 6.0M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | $17.58 | $11.32 |
| Revenue Next Year | $13.99 | $12.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $0.93 | $1.09 |
| 52 Week High | $5.05 | $2.73 |
Technical Indicators
Market Signals| Indicator | LDI | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 39.45 | 44.57 |
| Support Level | N/A | $1.27 |
| Resistance Level | $1.32 | $1.45 |
| Average True Range (ATR) | 0.07 | 0.09 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 37.38 | 19.44 |
Price Performance
Historical ComparisonAbout LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.